Valbiotis SA (EPA: ALVAL)
France
· Delayed Price · Currency is EUR 1.248
+0.036 (2.97%)
Nov 20, 2024, 1:39 PM CET
Valbiotis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 0.53 | 4.73 | 0.79 | 0.3 | 3.09 | 0.09 | Upgrade
|
| Revenue Growth (YoY) | -88.00% | 502.93% | 163.42% | -90.36% | 3297.80% | 15.19% | Upgrade
|
| Cost of Revenue | 3 | 2.04 | - | - | - | - | Upgrade
|
| Gross Profit | -2.48 | 2.69 | 0.79 | 0.3 | 3.09 | 0.09 | Upgrade
|
| Selling, General & Admin | 5.53 | 4.18 | 3.35 | 2.62 | 2.4 | 2.77 | Upgrade
|
| Research & Development | 5.33 | 7.15 | 9.1 | 7.03 | 5.4 | 3.97 | Upgrade
|
| Other Operating Expenses | -5.22 | -2.08 | -2.03 | -2.4 | -1.98 | -1.77 | Upgrade
|
| Operating Expenses | 6.59 | 9.85 | 12.77 | 8.7 | 6.5 | 5.25 | Upgrade
|
| Operating Income | -9.07 | -7.16 | -11.99 | -8.41 | -3.41 | -5.16 | Upgrade
|
| Interest Expense | -0.1 | -0.19 | -0.23 | -0.23 | -0.42 | -0.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.22 | - | -0.06 | 0.02 | -0 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -8.95 | -7.35 | -12.27 | -8.61 | -3.83 | -5.5 | Upgrade
|
| Other Unusual Items | -0 | -0.02 | -0.04 | -0.07 | - | -0 | Upgrade
|
| Pretax Income | -8.95 | -7.37 | -12.31 | -8.68 | -3.83 | -5.5 | Upgrade
|
| Income Tax Expense | -0.01 | - | -0 | - | - | - | Upgrade
|
| Net Income | -8.94 | -7.37 | -12.31 | -8.68 | -3.83 | -5.5 | Upgrade
|
| Net Income to Common | -8.94 | -7.37 | -12.31 | -8.68 | -3.83 | -5.5 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 12 | 10 | 9 | 7 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 12 | 10 | 9 | 7 | 5 | Upgrade
|
| Shares Change (YoY) | 23.46% | 23.21% | 10.45% | 22.88% | 58.63% | 24.66% | Upgrade
|
| EPS (Basic) | -0.63 | -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | Upgrade
|
| EPS (Diluted) | -0.63 | -0.59 | -1.22 | -0.95 | -0.51 | -1.17 | Upgrade
|
| Free Cash Flow | -7.44 | -8.08 | -9.3 | -7.46 | 2.53 | -4.98 | Upgrade
|
| Free Cash Flow Per Share | -0.53 | -0.65 | -0.92 | -0.81 | 0.34 | -1.06 | Upgrade
|
| Gross Margin | - | 56.81% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1720.68% | -151.28% | -1526.88% | -2820.81% | -110.19% | -5664.84% | Upgrade
|
| Profit Margin | -1697.15% | -155.67% | -1568.41% | -2913.09% | -123.84% | -6048.35% | Upgrade
|
| Free Cash Flow Margin | -1412.52% | -170.78% | -1185.10% | -2504.03% | 81.86% | -5470.33% | Upgrade
|
| EBITDA | -9.21 | -6.96 | -11.13 | -7.47 | -2.37 | -4.22 | Upgrade
|
| EBITDA Margin | - | -146.95% | - | - | -76.65% | - | Upgrade
|
| D&A For EBITDA | -0.14 | 0.21 | 0.85 | 0.94 | 1.04 | 0.94 | Upgrade
|
| EBIT | -9.07 | -7.16 | -11.99 | -8.41 | -3.41 | -5.16 | Upgrade
|
| EBIT Margin | - | -151.28% | - | - | -110.19% | - | Upgrade
|
| Revenue as Reported | 5.75 | 6.81 | 2.81 | 2.69 | 5.1 | 1.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.